GlassScriptPhysician profile
Virginia Lee Secrest
NPI 1275387441
$1,004.17
in general payments reported to CMS, 2019-2025
17 companies · $593 in 2025
The $593 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $412 · 2025: $593.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,004.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,004.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Endo USA, INC. | $223.73 | 2024-2025 | Xiaflex, Aveed |
| Medtronic, INC. | $165.80 | 2025 | Interstim |
| Bayer Healthcare Pharmaceuticals INC. | $109.65 | 2025 | |
| Astellas Pharma US INC | $84.29 | 2025 | Xtandi |
| Accord Healthcare, INC. | $79.33 | 2024 | |
| Axonics, INC. | $55.94 | 2024 | Axonics |
| Janssen Biotech, INC. | $39.15 | 2024 | Erleada |
| Ferring Pharmaceuticals INC. | $34.79 | 2025 | Adstiladrin |
| Urogen Pharma, INC. | $31.70 | 2024 | |
| Pfizer INC. | $30.89 | 2024 | |
| Merck Sharp & Dohme LLC | $27.66 | 2025 | Keytruda |
| Tolmar, INC. | $26.08 | 2024 | |
| Progenics Pharmaceuticals, INC. | $23.04 | 2024 | |
| Dendreon Pharmaceuticals LLC | $19.77 | 2024 | Provenge |
| Cycle Pharmaceuticals INC | $19.56 | 2025 | Venxxiva |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teleflex LLC | $18.70 | 2025 | Urolift |
| Antares Pharma, INC. | $14.09 | 2025 | Xyosted |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Virginia Secrest listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.